Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Chauvin C, Levillayer L, Roumier M, Nielly H, Roth C, Karnam A, Bonam SR, Bourgarit A, Dubost C, Bousquet A, Le Burel S, Mestiri R, Sene D, Galland J, Vasse M, Groh M, Le Marchand M, Vassord-Dang C, Gautier JF, Pham-Thi N, Verny C, Pitard B, Planchais C, Mouquet H, Paul R, Simon-Loriere E, Bayry J, Gilardin L, Sakuntabhai A. Chauvin C, et al. Among authors: levillayer l. iScience. 2023 Mar 17;26(3):106124. doi: 10.1016/j.isci.2023.106124. Epub 2023 Feb 3. iScience. 2023. PMID: 36776936 Free PMC article.
SARS-CoV-2 Induces Cytokine Responses in Human Basophils.
Bonam SR, Chauvin C, Levillayer L, Mathew MJ, Sakuntabhai A, Bayry J. Bonam SR, et al. Among authors: levillayer l. Front Immunol. 2022 Feb 24;13:838448. doi: 10.3389/fimmu.2022.838448. eCollection 2022. Front Immunol. 2022. PMID: 35280992 Free PMC article.
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.
Frantz PN, Barinov A, Ruffié C, Combredet C, Najburg V, de Melo GD, Larrous F, Kergoat L, Teeravechyan S, Jongkaewwattana A, Billon-Denis E, Tournier JN, Prot M, Levillayer L, Conquet L, Montagutelli X, Tichit M, Hardy D, Fernandes P, Strick-Marchand H, Di Santo J, Simon-Lorière E, Bourhy H, Tangy F. Frantz PN, et al. Among authors: levillayer l. Nat Commun. 2021 Nov 1;12(1):6277. doi: 10.1038/s41467-021-26506-2. Nat Commun. 2021. PMID: 34725327 Free PMC article.
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.
Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckier F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachia A, Friedlander G, Chrétien F, Simon-Loriere E, Gaillard R. Plaze M, et al. Among authors: levillayer l. Int J Antimicrob Agents. 2021 Mar;57(3):106274. doi: 10.1016/j.ijantimicag.2020.106274. Epub 2020 Dec 30. Int J Antimicrob Agents. 2021. PMID: 33387629 Free PMC article.
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
Roth C, Cantaert T, Colas C, Prot M, Casadémont I, Levillayer L, Thalmensi J, Langlade-Demoyen P, Gerke C, Bahl K, Ciaramella G, Simon-Loriere E, Sakuntabhai A. Roth C, et al. Among authors: levillayer l. Front Immunol. 2019 Jun 21;10:1424. doi: 10.3389/fimmu.2019.01424. eCollection 2019. Front Immunol. 2019. PMID: 31293584 Free PMC article.